Advancing Informed and Appropriate Use of ADHD Treatments

Mindful Moment

  • Supporting Young Adults with ADHD: What We Learned

    Supporting Young Adults with ADHD: What We Learned

    “The answer cannot be to leave people navigating an increasingly complex marketplace on their own. We need better research, better clinician education, and more open conversations about what is evidence-based, what is still emerging, and how different supports can be safely incorporated into individualized care.” — Jakara Eason, Executive Director, Mindful Choices for ADHD Last Wednesday,…

    read more

  • There Is No One-Size-Fits-All Approach to ADHD

    There Is No One-Size-Fits-All Approach to ADHD

    Better policy begins with better information. Hosted by Mindful Choices for ADHD in cooperation with the Bipartisan Mental Health Caucus, this Congressional briefing marked an important milestone in bringing an evidence-based conversation about ADHD to Capitol Hill. Dozens of Congressional staff, clinicians, researchers, and individuals with lived experience gathered to discuss the science of ADHD,…

    read more

  • Summit Series Session One Key Takeaways

    Summit Series Session One Key Takeaways

    “The transition for adolescents with ADHD to adulthood is really a perfect storm.” – George DuPaul, PhD On June 17 Mindful Choices hosted the first session of our Virtual Summer Summit Series, Thriving in Transition: Reimagining ADHD Care for Young Adults. Bringing together experts, clinicians, and individuals with lived experience, the conversation explored one of…

    read more

  • The Importance of Lived Experience in Shaping ADHD Policy

    The Importance of Lived Experience in Shaping ADHD Policy

    This week, Mindful Choices Executive Director, Jakara Eason, and Chief Science Officer, Dr. Shanta Whitaker, joined Jessica Lewis on the Quick Wins for ADHD Moms podcast for a conversation about the importance of bringing lived experience into national ADHD conversations. Jessica serves on the Mindful Choices Steering Committee and brings valuable insights as both an individual living with ADHD and a parent navigating…

    read more

  • The Need for More Clinician Resources

    The Need for More Clinician Resources

    According to a study published in JAMA Psychiatry, about half of ADHD stimulant prescriptions dispensed in the United States originated from primary care clinicians, with nurse practitioners accounting for approximately 40% of prescriptions within that group. This reflects a broader shift in where ADHD care is being delivered. For many individuals, primary care providers are often the…

    read more

  • Session One Speakers Announced! Young Adults with ADHD: Lost in Transition Virtual Summit

    Session One Speakers Announced! Young Adults with ADHD: Lost in Transition Virtual Summit

    Mindful Choices is excited to announce the speaker lineup for our first Virtual Summer Summit Series session: Young Adults with ADHD: Lost in Transition, on June 17 from 12:30-2 PM EST. We are honored to welcome a distinguished group of nationally recognized clinicians, researchers, and advocates who are helping shape the conversation around ADHD care across the…

    read more

  • ICYMI The Latest Research on Adult ADHD from Mindful Choices Steering Committee Member

    ICYMI The Latest Research on Adult ADHD from Mindful Choices Steering Committee Member

    “ADHD is the second most prevalent psychiatric disorder in the adult population, with an adult presentation of 3%, but in the clinical practice setting, that can be three to sevenfold higher.” – David Goodman, MD In a recent Psychiatric Times interview, Dr. Goodman highlighted an important challenge in ADHD care: many clinicians receive limited formal training in…

    read more

  • Navigating the National ADHD Policy Conversation

    Navigating the National ADHD Policy Conversation

    During Mental Health Awareness Month, we are leaning into our role to improve understanding in the policy community of ADHD and the experiences of individuals and families impacted by it. This is particularly critical and timely as conversations around mental health and psychiatric medications continue to evolve at the national policy level. These conversations impact individuals,…

    read more

  • RFK Jr. Says Trump Administration Will Promote “Deprescribing’ of Psychiatric Medications, While Encouraging More Clinician Training and Transparency Between Patients and Prescribers

    RFK Jr. Says Trump Administration Will Promote “Deprescribing’ of Psychiatric Medications, While Encouraging More Clinician Training and Transparency Between Patients and Prescribers

    FOR IMMEDIATE RELEASEContact: Jakara [email protected] May 6, 2026 WASHINGTON, DC – In a major announcement this week, Secretary Kennedy, who leads the U.S. Department of Health and Human Services, announced that the department will take major new steps to combat “the overuse of psychiatric medications – especially among children.” The initiative advances priorities of the “Make America…

    read more